ORAL PHARMACEUTICAL EXTENDED RELEASE DOSAGE FORM

摘要

An enteric coated pharmaceutical extended release dosage form of an H +,K + -ATPase inhibitor giving an extended plasma concentration profile of an H +,K + -ATPase inhibitor. The extended plasma profile is obtained by a pharmaceutical composition which comprises a core material of a hydrophilic or hydrophobic matrix, and the H +,K + -ATPase inhibitor and optionally pharmaceutically acceptable excipients. The dosage form may be administered once daily.